LOX and osteoporosis: Teriparatide has been reported to improve bone quality by inhibiting non-physiological cross-linking, such as pentosidine cross-linking caused by AGEs, and promoting physiological cross-linking by production of lysyl oxidase in osteoblasts, which may be effective as a treatment for osteoporosis in patients with T2DM [16].